Osteopontin Is a Blood Biomarker for Microglial Activation and Brain Injury in Experimental Hypoxic-Ischemic Encephalopathy

Clinical management of neonatal hypoxic-ischemic encephalopathy (HIE) suffers from the lack of reliable surrogate marker tests. Proteomic analysis may identify such biomarkers in blood, but there has been no proof-of-principle evidence to support this approach. Here we performed in-gel trypsin diges...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yikun, Dammer, Eric B., Zhang-Brotzge, Xiaohui, Chen, Scott, Duong, Duc M., Seyfried, Nicholas T., Kuan, Chia-Yi, Sun, Yu-Yo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Neuroscience 2017
Materias:
New Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223053/
https://www.ncbi.nlm.nih.gov/pubmed/28101531
http://dx.doi.org/10.1523/ENEURO.0253-16.2016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223053/
https://www.ncbi.nlm.nih.gov/pubmed/28101531
http://dx.doi.org/10.1523/ENEURO.0253-16.2016

Ejemplares similares